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and anti-G3 quantitative Western blot showed aggrecan fragment
patterns for individual subjects, allowing a detailed comparison
of aggrecan proteolysis in different human joint diseases and dis-
ease stages. SF aggrecan fragment patters differed signiﬁcantly
between different human joint diseases, suggesting differences
in protease activity and or structure of the cartilage matrix sub-
strate. Use of additional antibodies will allow quantiﬁcation of
other aggrecan fragments. The method can help identify new OA
biomarkers. It is also suitable for in vitro screening of protease
inhibitors and in early development of disease modifying therapy
of human joint diseases.
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Purpose: Biochemical markers (BM) may be useful to assess
disease progression and efﬁcacy of treatments in osteoarthritis
(OA). The clinical utility of BMs depends on two components: 1)
their sensitivity to detect changes with disease or treatment and
2) their biological variability which may be affected by food intake.
The aim of this study was to evaluate the effect of food intake on
the concentration and the between day intra-subject variability of
BMs in untreated patients with knee OA and in healthy subjects
of similar age.
Methods: We recruited 22 patients (13 women, 9 men, mean
age 58 yr) with radiographic knee OA (12 with Kellgren-Lawrence
[KL] score 2 and 10 with KL score 3) and 10 healthy subjects
(7 women, 3 men, mean age: 47 yr) with no radiographic OA
at the knees, hips and spine. No subject was treated with any
investigational OA drugs, estrogen or bisphosphonate within the
previous 3-6 months and during the 14 days study period. When
receiving NSAIDs and/or dietary supplements, no change in
therapy was permitted during the study. For each subject and
at each of the 3 visits (day 1, day 7 and day 14), morning
blood samples were collected at two time points: fasting (F) at
7.45 before an 8.00 breakfast and non-fasting (NF) at 10.00,
2 hours after breakfast. Second morning void urine was also
collected at each 3 visits. The following serum (S) and urine
(U) BMs were measured: S-CTX-I, a BM of bone resorption,
S-COMP, a BM of cartilage turnover, S-PIIANP, a BM of cartilage
synthesis, hyaluronic acid (S-HA), a BM of synovitis, U-CTX-II,
a BM of cartilage degradation and U-Glc-Gal-PYD, a BM of
synovial tissue metabolism. For S-BMs, the difference in levels
between NF and F state was calculated and the intra-subject
variability was estimated by mixed model ANOVA.
Results: Patients with knee OA had higher median levels of S-
COMP (+30%, p=0.02 and +24%, p=0.05 for F and NF samples,
respectively), S-HA (+48%, p=0.02 and +13%, p=0.12 for F
and NF samples) and CTX-II (+108%, p<0.01) than healthy
controls. Patients with knee OA KL score 3 had higher F-levels
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S-CTX-I S-COMP S-PIIANP S-HA
% NF-F CVi-F CVi-NF %NF-F CVi -F CVi -NF % NF-F CVi -F CVi -NF % NF-F CVi -F CVi-NF
All -52%** 12.9 28.6 0.1% 8.8 8.8 -2.0% 19.7 25.1 +33%** 34.3 34.2
Knee OA -52%** 12.5 29.8 -0.1% 8.5 8.9 -1.9% 19.6 25.7 +30%** 36.1 37.0
Healthy -51%* 13.0 23.9 0.4% 9.2 8.0 -8.9% 20.4 20.6 +45%* 19.7 22.0
*p<0.01, **p<0.001.
of S-CTX-I (+64%, p=0.02), S-COMP (+37%, p=0.02), S-HA
(+68%, p=0.03), U-CTX-II (+151%, p<0.001) and U-Glc-Gal-
PYD (+53%, p=0.01) than patients with KL-2. When measured
on NF samples, the difference between patients with KL-2 and
KL-3 was not anymore signiﬁcant for S-CTX-I and S-HA. The
table shows the difference of S-BM levels in NF compared with F
state as a percentage (% NF-F) and the intra subject coefﬁcient
of variation (CVi%) in all subjects, in patients with knee OA, and
in healthy controls and in F (CVi-F) and NF (CVi-NF) conditions.
For urinary markers, the intra-subject variability in all subjects,
knee OA patients and healthy controls were respectively 23.1%,
19.6% and 30.5% for U-CTX-II and 21.1%, 22.3% and 16.4% for
U-Glc-Gal-PYD.
Conclusions: Food intake has a marked inﬂuence on the levels
of S-CTX-I and S-HA and increases variability of S-CTX-I, but has
small effects on S-COMP and S-PIIANP. The association of S-
BMs with OA was higher when measured on F than NF samples.
Standardized collection of fasting sample is recommended for
measuring BM in OA.
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Purpose: Rheumatoid Arthritis (RA) is a chronic auto-immune
disease with aggressive and extensive articular cartilage destruc-
tion. Aggrecan is the major proteoglycan of articular cartilage,
and is composed of three globular domains (G1-G3). Aggrecan
depletion, mediated by aggrecanases is one of the ﬁrst signs of
early cartilage erosion. We investigated, whether measurement
of aggrecan and fragments thereof in serum, could be used as
biomarkers for joint-disease in RA patients.
Methods: For the veriﬁcation of release of intact aggrecan and
degradation fragments, we used catabolically stimulated human
cartilage explants from a late stage 42 year old female patient
with osteoarthritis (OA). Pieces of cartilage (12-16 mg) were
placed in 96 well plates in 4-replicates and incubated for 21
days at 37°C with 5% CO2 and shaking (50 rpm). Serum-free
D-MEM medium was used. Explants were incubated with either
medium alone, or 10 and 20 ng/ml of the pro-inﬂammatory
cytokines OSM/TNFα respectively. As negative control, cartilage
was placed in cryo-tubes, frozen in liquid N2 and thawed at 37°C
in water-bath for three repeated freeze-thaw cycles. The explant
culture medium was replaced every 3rd day for 21 days.
The study co-hort consisted of 108 healthy individuals and 38
patients diagnosed with RA (61.3±19.3 years, 71.05 ±14.5
kg, 4.7±1.6 disease activity score). Aggrecan levels were in-
vestigated by, 1) 374ARGSVI-G2 sandwich assay measuring
aggrecanase-mediated aggrecan degradation, or 2) G1/G2 sand-
wich assay, believed to account for the total turnover of aggre-
can. We further characterised serum samples by western blots,
